Quantitation of novel pentavalent meningococcal polysaccharide conjugate vaccine (Men A-TT, Men C-CRM, Men Y-CRM, Men W-CRM, Men X-TT) using sandwich ELISA

Meningococcal vaccines have been developed over the years, to control outbreaks of meningitis. There are 12 immunologically distinct serogroups of which, A, B, C, W, Y and X are predominant and invasive in nature. Meningococcal vaccines can be sorted out as, polysaccharide vaccines, polysaccharide p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2020-11, Vol.38 (49), p.7815-7824
Hauptverfasser: Phugare, Swapnil, Kale, Sameer, Sharma, Pankaj, Kumar Goel, Sunil, Gairola, Sunil, Jadhav, Suresh S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 7824
container_issue 49
container_start_page 7815
container_title Vaccine
container_volume 38
creator Phugare, Swapnil
Kale, Sameer
Sharma, Pankaj
Kumar Goel, Sunil
Gairola, Sunil
Jadhav, Suresh S.
description Meningococcal vaccines have been developed over the years, to control outbreaks of meningitis. There are 12 immunologically distinct serogroups of which, A, B, C, W, Y and X are predominant and invasive in nature. Meningococcal vaccines can be sorted out as, polysaccharide vaccines, polysaccharide protein conjugate vaccines or protein based (independent of polysaccharides) vaccines. Stringent quality control analysis as per the regulatory guidelines is a requirement for any vaccine manufacturer for commercial release of vaccines. Quantitation becomes challenging when it comes to analysis of multivalent vaccines. We describe the quantitation of novel pentavalent meningococcal polysaccharide conjugate vaccine manufactured at Serum Institute of India Pvt Ltd (SIIPL). Briefly, sandwich ELISA assay was developed to quantitate five different serogroups (Men A-TT, Men C-CRM, Men Y-CRM, Men W-CRM, Men X-TT) in pentavalent meningococcal polysaccharide conjugate vaccine containing two different carrier proteins (TT and CRM). ELISA reported herein showed significant reproducibility and repeatability over a range of developed standard curve with acceptable coefficient of variation (
doi_str_mv 10.1016/j.vaccine.2020.10.017
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2458959311</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X20313086</els_id><sourcerecordid>2458959311</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-d0df429d31cffa61a175c655dd6e7d5c17b5984cbe72be83b89b21cb714c2c193</originalsourceid><addsrcrecordid>eNqFkdtu1DAQhi1ERZfCI4AscVOkZrHjOIcrtFq1tNJWCFhEubKc8aR1lLWXONmqz8LL1tEuVOKGq_k1881B8xPyhrM5Zzz_0M53GsA6nKcsnXJzxotnZMbLQiSp5OVzMmNpniUZZzfH5GUILWNMCl69IMdC8DwrWTYjv7-M2g120IP1jvqGOr_Djm7RDXqnuxjoBp11tx48gI4V3z2EuPlO99YgBe_a8VYPSA_n0NNrdHSRrNdndFLLZPn1ei9_PskfT_Imou_pGOIOGrQz9xbu6Pnq6tviFTlqdBfw9SGekO8X5-vlZbL6_OlquVglICoxJIaZJksrIzg0jc655oWEXEpjciyMBF7UsiozqLFIayxFXVZ1yqEueAYp8EqckNP93G3vf40YBrWxAbDrtEM_BpVmsqxkJTiP6Lt_0NaPvYvXTVQhy0zIMlJyT0HvQ-ixUdvebnT_oDhTk3uqVYd3qcm9KR3di31vD9PHeoPmb9cfuyLwcQ9gfMfOYq8CWHSAxvYIgzLe_mfFI3_4q6I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2457584358</pqid></control><display><type>article</type><title>Quantitation of novel pentavalent meningococcal polysaccharide conjugate vaccine (Men A-TT, Men C-CRM, Men Y-CRM, Men W-CRM, Men X-TT) using sandwich ELISA</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>ProQuest Central</source><creator>Phugare, Swapnil ; Kale, Sameer ; Sharma, Pankaj ; Kumar Goel, Sunil ; Gairola, Sunil ; Jadhav, Suresh S.</creator><creatorcontrib>Phugare, Swapnil ; Kale, Sameer ; Sharma, Pankaj ; Kumar Goel, Sunil ; Gairola, Sunil ; Jadhav, Suresh S.</creatorcontrib><description>Meningococcal vaccines have been developed over the years, to control outbreaks of meningitis. There are 12 immunologically distinct serogroups of which, A, B, C, W, Y and X are predominant and invasive in nature. Meningococcal vaccines can be sorted out as, polysaccharide vaccines, polysaccharide protein conjugate vaccines or protein based (independent of polysaccharides) vaccines. Stringent quality control analysis as per the regulatory guidelines is a requirement for any vaccine manufacturer for commercial release of vaccines. Quantitation becomes challenging when it comes to analysis of multivalent vaccines. We describe the quantitation of novel pentavalent meningococcal polysaccharide conjugate vaccine manufactured at Serum Institute of India Pvt Ltd (SIIPL). Briefly, sandwich ELISA assay was developed to quantitate five different serogroups (Men A-TT, Men C-CRM, Men Y-CRM, Men W-CRM, Men X-TT) in pentavalent meningococcal polysaccharide conjugate vaccine containing two different carrier proteins (TT and CRM). ELISA reported herein showed significant reproducibility and repeatability over a range of developed standard curve with acceptable coefficient of variation (&lt;15%) for both intra and inter assay. Furthermore analysis showed that, polysaccharide conjugate (PC) contents were within the accepted range (±30%) of the stated label claim. The immunoassay was verified for its sensitivity, accuracy and precision. Based on the relevant experimental data; it is proposed that, reported sandwich ELISA is well suited for quantitation of individual polysaccharide conjugate from pentavalent formulation. Furthermore, the ELISA was explored for forced degradation and polysaccharide spiking studies. This leads to open up an area of research for sandwich ELISA as a tool to assess the integrity of vaccine as well as for lot to lot consistency monitoring.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2020.10.017</identifier><identifier>PMID: 33164804</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Acids ; Antibodies ; Antibodies, Bacterial ; Antigens ; Coefficient of variation ; Conjugates ; CRM ; ELISA ; Enzyme-Linked Immunosorbent Assay ; Humans ; Immunoassay ; India ; Male ; Meningitis ; Meningococcal Infections ; Meningococcal serogroup X ; Meningococcal Vaccines ; Polysaccharides ; Potassium ; Proteins ; Quality control ; Quantitation ; Reproducibility ; Reproducibility of Results ; Saccharides ; Vaccines ; Vaccines, Combined ; Vaccines, Conjugate</subject><ispartof>Vaccine, 2020-11, Vol.38 (49), p.7815-7824</ispartof><rights>2020 Elsevier Ltd</rights><rights>Copyright © 2020 Elsevier Ltd. All rights reserved.</rights><rights>2020. Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-d0df429d31cffa61a175c655dd6e7d5c17b5984cbe72be83b89b21cb714c2c193</citedby><cites>FETCH-LOGICAL-c393t-d0df429d31cffa61a175c655dd6e7d5c17b5984cbe72be83b89b21cb714c2c193</cites><orcidid>0000-0003-4093-9736</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2457584358?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976,64364,64366,64368,72218</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33164804$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Phugare, Swapnil</creatorcontrib><creatorcontrib>Kale, Sameer</creatorcontrib><creatorcontrib>Sharma, Pankaj</creatorcontrib><creatorcontrib>Kumar Goel, Sunil</creatorcontrib><creatorcontrib>Gairola, Sunil</creatorcontrib><creatorcontrib>Jadhav, Suresh S.</creatorcontrib><title>Quantitation of novel pentavalent meningococcal polysaccharide conjugate vaccine (Men A-TT, Men C-CRM, Men Y-CRM, Men W-CRM, Men X-TT) using sandwich ELISA</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Meningococcal vaccines have been developed over the years, to control outbreaks of meningitis. There are 12 immunologically distinct serogroups of which, A, B, C, W, Y and X are predominant and invasive in nature. Meningococcal vaccines can be sorted out as, polysaccharide vaccines, polysaccharide protein conjugate vaccines or protein based (independent of polysaccharides) vaccines. Stringent quality control analysis as per the regulatory guidelines is a requirement for any vaccine manufacturer for commercial release of vaccines. Quantitation becomes challenging when it comes to analysis of multivalent vaccines. We describe the quantitation of novel pentavalent meningococcal polysaccharide conjugate vaccine manufactured at Serum Institute of India Pvt Ltd (SIIPL). Briefly, sandwich ELISA assay was developed to quantitate five different serogroups (Men A-TT, Men C-CRM, Men Y-CRM, Men W-CRM, Men X-TT) in pentavalent meningococcal polysaccharide conjugate vaccine containing two different carrier proteins (TT and CRM). ELISA reported herein showed significant reproducibility and repeatability over a range of developed standard curve with acceptable coefficient of variation (&lt;15%) for both intra and inter assay. Furthermore analysis showed that, polysaccharide conjugate (PC) contents were within the accepted range (±30%) of the stated label claim. The immunoassay was verified for its sensitivity, accuracy and precision. Based on the relevant experimental data; it is proposed that, reported sandwich ELISA is well suited for quantitation of individual polysaccharide conjugate from pentavalent formulation. Furthermore, the ELISA was explored for forced degradation and polysaccharide spiking studies. This leads to open up an area of research for sandwich ELISA as a tool to assess the integrity of vaccine as well as for lot to lot consistency monitoring.</description><subject>Acids</subject><subject>Antibodies</subject><subject>Antibodies, Bacterial</subject><subject>Antigens</subject><subject>Coefficient of variation</subject><subject>Conjugates</subject><subject>CRM</subject><subject>ELISA</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Humans</subject><subject>Immunoassay</subject><subject>India</subject><subject>Male</subject><subject>Meningitis</subject><subject>Meningococcal Infections</subject><subject>Meningococcal serogroup X</subject><subject>Meningococcal Vaccines</subject><subject>Polysaccharides</subject><subject>Potassium</subject><subject>Proteins</subject><subject>Quality control</subject><subject>Quantitation</subject><subject>Reproducibility</subject><subject>Reproducibility of Results</subject><subject>Saccharides</subject><subject>Vaccines</subject><subject>Vaccines, Combined</subject><subject>Vaccines, Conjugate</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkdtu1DAQhi1ERZfCI4AscVOkZrHjOIcrtFq1tNJWCFhEubKc8aR1lLWXONmqz8LL1tEuVOKGq_k1881B8xPyhrM5Zzz_0M53GsA6nKcsnXJzxotnZMbLQiSp5OVzMmNpniUZZzfH5GUILWNMCl69IMdC8DwrWTYjv7-M2g120IP1jvqGOr_Djm7RDXqnuxjoBp11tx48gI4V3z2EuPlO99YgBe_a8VYPSA_n0NNrdHSRrNdndFLLZPn1ei9_PskfT_Imou_pGOIOGrQz9xbu6Pnq6tviFTlqdBfw9SGekO8X5-vlZbL6_OlquVglICoxJIaZJksrIzg0jc655oWEXEpjciyMBF7UsiozqLFIayxFXVZ1yqEueAYp8EqckNP93G3vf40YBrWxAbDrtEM_BpVmsqxkJTiP6Lt_0NaPvYvXTVQhy0zIMlJyT0HvQ-ixUdvebnT_oDhTk3uqVYd3qcm9KR3di31vD9PHeoPmb9cfuyLwcQ9gfMfOYq8CWHSAxvYIgzLe_mfFI3_4q6I</recordid><startdate>20201117</startdate><enddate>20201117</enddate><creator>Phugare, Swapnil</creator><creator>Kale, Sameer</creator><creator>Sharma, Pankaj</creator><creator>Kumar Goel, Sunil</creator><creator>Gairola, Sunil</creator><creator>Jadhav, Suresh S.</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4093-9736</orcidid></search><sort><creationdate>20201117</creationdate><title>Quantitation of novel pentavalent meningococcal polysaccharide conjugate vaccine (Men A-TT, Men C-CRM, Men Y-CRM, Men W-CRM, Men X-TT) using sandwich ELISA</title><author>Phugare, Swapnil ; Kale, Sameer ; Sharma, Pankaj ; Kumar Goel, Sunil ; Gairola, Sunil ; Jadhav, Suresh S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-d0df429d31cffa61a175c655dd6e7d5c17b5984cbe72be83b89b21cb714c2c193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Acids</topic><topic>Antibodies</topic><topic>Antibodies, Bacterial</topic><topic>Antigens</topic><topic>Coefficient of variation</topic><topic>Conjugates</topic><topic>CRM</topic><topic>ELISA</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Humans</topic><topic>Immunoassay</topic><topic>India</topic><topic>Male</topic><topic>Meningitis</topic><topic>Meningococcal Infections</topic><topic>Meningococcal serogroup X</topic><topic>Meningococcal Vaccines</topic><topic>Polysaccharides</topic><topic>Potassium</topic><topic>Proteins</topic><topic>Quality control</topic><topic>Quantitation</topic><topic>Reproducibility</topic><topic>Reproducibility of Results</topic><topic>Saccharides</topic><topic>Vaccines</topic><topic>Vaccines, Combined</topic><topic>Vaccines, Conjugate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Phugare, Swapnil</creatorcontrib><creatorcontrib>Kale, Sameer</creatorcontrib><creatorcontrib>Sharma, Pankaj</creatorcontrib><creatorcontrib>Kumar Goel, Sunil</creatorcontrib><creatorcontrib>Gairola, Sunil</creatorcontrib><creatorcontrib>Jadhav, Suresh S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Phugare, Swapnil</au><au>Kale, Sameer</au><au>Sharma, Pankaj</au><au>Kumar Goel, Sunil</au><au>Gairola, Sunil</au><au>Jadhav, Suresh S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Quantitation of novel pentavalent meningococcal polysaccharide conjugate vaccine (Men A-TT, Men C-CRM, Men Y-CRM, Men W-CRM, Men X-TT) using sandwich ELISA</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2020-11-17</date><risdate>2020</risdate><volume>38</volume><issue>49</issue><spage>7815</spage><epage>7824</epage><pages>7815-7824</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>Meningococcal vaccines have been developed over the years, to control outbreaks of meningitis. There are 12 immunologically distinct serogroups of which, A, B, C, W, Y and X are predominant and invasive in nature. Meningococcal vaccines can be sorted out as, polysaccharide vaccines, polysaccharide protein conjugate vaccines or protein based (independent of polysaccharides) vaccines. Stringent quality control analysis as per the regulatory guidelines is a requirement for any vaccine manufacturer for commercial release of vaccines. Quantitation becomes challenging when it comes to analysis of multivalent vaccines. We describe the quantitation of novel pentavalent meningococcal polysaccharide conjugate vaccine manufactured at Serum Institute of India Pvt Ltd (SIIPL). Briefly, sandwich ELISA assay was developed to quantitate five different serogroups (Men A-TT, Men C-CRM, Men Y-CRM, Men W-CRM, Men X-TT) in pentavalent meningococcal polysaccharide conjugate vaccine containing two different carrier proteins (TT and CRM). ELISA reported herein showed significant reproducibility and repeatability over a range of developed standard curve with acceptable coefficient of variation (&lt;15%) for both intra and inter assay. Furthermore analysis showed that, polysaccharide conjugate (PC) contents were within the accepted range (±30%) of the stated label claim. The immunoassay was verified for its sensitivity, accuracy and precision. Based on the relevant experimental data; it is proposed that, reported sandwich ELISA is well suited for quantitation of individual polysaccharide conjugate from pentavalent formulation. Furthermore, the ELISA was explored for forced degradation and polysaccharide spiking studies. This leads to open up an area of research for sandwich ELISA as a tool to assess the integrity of vaccine as well as for lot to lot consistency monitoring.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>33164804</pmid><doi>10.1016/j.vaccine.2020.10.017</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-4093-9736</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0264-410X
ispartof Vaccine, 2020-11, Vol.38 (49), p.7815-7824
issn 0264-410X
1873-2518
language eng
recordid cdi_proquest_miscellaneous_2458959311
source MEDLINE; Elsevier ScienceDirect Journals; ProQuest Central
subjects Acids
Antibodies
Antibodies, Bacterial
Antigens
Coefficient of variation
Conjugates
CRM
ELISA
Enzyme-Linked Immunosorbent Assay
Humans
Immunoassay
India
Male
Meningitis
Meningococcal Infections
Meningococcal serogroup X
Meningococcal Vaccines
Polysaccharides
Potassium
Proteins
Quality control
Quantitation
Reproducibility
Reproducibility of Results
Saccharides
Vaccines
Vaccines, Combined
Vaccines, Conjugate
title Quantitation of novel pentavalent meningococcal polysaccharide conjugate vaccine (Men A-TT, Men C-CRM, Men Y-CRM, Men W-CRM, Men X-TT) using sandwich ELISA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T15%3A37%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Quantitation%20of%20novel%20pentavalent%20meningococcal%20polysaccharide%20conjugate%20vaccine%20(Men%20A-TT,%20Men%20C-CRM,%20Men%20Y-CRM,%20Men%20W-CRM,%20Men%20X-TT)%20using%20sandwich%20ELISA&rft.jtitle=Vaccine&rft.au=Phugare,%20Swapnil&rft.date=2020-11-17&rft.volume=38&rft.issue=49&rft.spage=7815&rft.epage=7824&rft.pages=7815-7824&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2020.10.017&rft_dat=%3Cproquest_cross%3E2458959311%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2457584358&rft_id=info:pmid/33164804&rft_els_id=S0264410X20313086&rfr_iscdi=true